Core Viewpoint - Active equity funds have significantly outperformed passive index funds in the year to date, driven by strong performance in sectors like pharmaceuticals and Hong Kong stocks [1][2]. Group 1: Performance Comparison - As of July 9, the best-performing active equity fund achieved a return close to 100%, outperforming the highest index fund return by nearly 34 percentage points [2][3]. - The top ten performing equity funds are all active products, primarily focused on themes related to Hong Kong, pharmaceuticals, and the Beijing Stock Exchange [3]. - The top-performing active fund, Huatai-PineBridge Hong Kong Advantage Selection A, recorded a return of 98.16%, followed by several other funds with returns ranging from 68.19% to 81.45% [4]. Group 2: Broader Fund Performance - Among the top twenty funds, six are active equity funds, while the remaining are ETFs, with the best-performing ETFs showing returns significantly lower than those of active funds [5]. - The average return for ordinary stock funds was 9.06%, while stock index funds averaged 6.29% [5][6]. Group 3: Market Outlook - The market outlook for the second half of the year suggests opportunities beyond pharmaceuticals, including technology, dividends, and new consumption sectors [9][10]. - Analysts expect a moderate economic recovery supported by domestic growth policies and liquidity easing, leading to a bullish trend in A-shares and Hong Kong stocks [10][11]. - Key investment themes for the second half include growth industries, quality technology assets, and emerging consumer sectors, with a focus on innovative pharmaceuticals [12].
年内最高收益近100%!主动权益基金投资优势凸显
券商中国·2025-07-09 15:20